Illustrative image – not actual.The Ministry of Health has announced plans to set up a vaccine manufacturing facility in Nairobi, Kenya to support production of various vaccines including COVID-19 jabs.
The Biovax plant at the Kenya Medical Supplies Authority (KEMSA) facility in Embakasi will be installed at a cost of KES 2.5 billion. The plant will be located at the KEMSA grounds in Embakasi and the government has already acquired the required land.
Under the National COVID-19 Vaccine Deployment Plan, Kenya aims to have fully-fledged vaccine manufacturing capability by 2024.
The Biovax plant at the Kenya Medical Supplies Authority (KEMSA) facility in Embakasi will be installed at a cost of KES 2.5 billion. The plant will be located at the KEMSA grounds in Embakasi and the government has already acquired the required land.
Under the National COVID-19 Vaccine Deployment Plan, Kenya aims to have fully-fledged vaccine manufacturing capability by 2024.
